Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale.
Culture viraleDiagnostic viral
#2
Quels échantillons sont utilisés pour la culture virale ?
Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies.
Échantillons biologiquesCulture virale
#3
Quels tests complètent la culture virale ?
Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale.
Tests de laboratoireDiagnostic viral
#4
Combien de temps prend une culture virale ?
La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus.
Culture viraleTemps de culture
#5
Quels signes indiquent une infection virale dans une culture ?
L'apparition de cytopathies ou de plaques de lyse indique une infection virale.
Infection viraleCulture virale
Symptômes
5
#1
Quels symptômes peuvent indiquer une infection virale ?
Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents.
SymptômesInfection virale
#2
Les symptômes varient selon le virus ?
Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme.
VirusSymptômes
#3
Comment les symptômes évoluent-ils avec une infection virale ?
Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire.
Réponse immunitaireInfection virale
#4
Les symptômes sont-ils toujours présents lors d'une culture virale ?
Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture.
AsymptomatiqueCulture virale
#5
Quels symptômes nécessitent une culture virale urgente ?
Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture.
Urgence médicaleCulture virale
Prévention
5
#1
Comment prévenir les infections virales ?
Vaccination, hygiène des mains et éviter le contact avec des personnes infectées.
PréventionVaccination
#2
Les vaccins sont-ils efficaces contre tous les virus ?
Non, chaque vaccin cible des virus spécifiques et leur efficacité varie.
VaccinsPrévention
#3
Quelles mesures d'hygiène sont recommandées ?
Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées.
HygiènePrévention
#4
Les masques aident-ils à prévenir les infections virales ?
Oui, les masques réduisent la transmission des virus respiratoires.
MasquesPrévention
#5
Les voyages augmentent-ils le risque d'infection virale ?
Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies.
VoyagesInfection virale
Traitements
5
#1
Quels traitements sont disponibles pour les infections virales ?
Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés.
AntivirauxTraitement antiviral
#2
La culture virale aide-t-elle à choisir un traitement ?
Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux.
Culture viraleTraitement antiviral
#3
Les antibiotiques sont-ils efficaces contre les virus ?
Non, les antibiotiques ne sont efficaces que contre les infections bactériennes.
AntibiotiquesInfection virale
#4
Comment les antiviraux agissent-ils ?
Ils inhibent la réplication virale ou modulent la réponse immunitaire.
AntivirauxRéponse immunitaire
#5
Les traitements sont-ils les mêmes pour tous les virus ?
Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie.
VirusTraitement antiviral
Complications
5
#1
Quelles complications peuvent survenir après une infection virale ?
Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir.
ComplicationsInfection virale
#2
Les complications sont-elles prévisibles ?
Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient.
ComplicationsÉtat de santé
#3
Comment les complications sont-elles traitées ?
Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques.
TraitementComplications
#4
Les enfants sont-ils plus à risque de complications ?
Oui, certains virus peuvent entraîner des complications plus graves chez les enfants.
EnfantsComplications
#5
Les personnes âgées sont-elles plus vulnérables aux complications ?
Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications.
Personnes âgéesComplications
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'infection virale ?
Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque.
Facteurs de risqueInfection virale
#2
L'âge influence-t-il le risque d'infection virale ?
Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales.
ÂgeInfection virale
#3
Les maladies chroniques augmentent-elles le risque ?
Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection.
Maladies chroniquesFacteurs de risque
#4
Le mode de vie influence-t-il le risque d'infection virale ?
Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque.
Mode de vieFacteurs de risque
#5
Les voyages à l'étranger augmentent-ils le risque d'infection ?
Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement.
VoyagesInfection virale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture virale : Questions médicales les plus fréquentes",
"headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méthode des plages virales",
"alternateName": "Viral Plaque Assay",
"url": "https://questionsmedicales.fr/mesh/D010948",
"about": {
"@type": "MedicalCondition",
"name": "Méthode des plages virales",
"code": {
"@type": "MedicalCode",
"code": "D010948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.970.790"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture virale",
"alternateName": "Virus Cultivation",
"code": {
"@type": "MedicalCode",
"code": "D014776",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arvind Varsani",
"url": "https://questionsmedicales.fr/author/Arvind%20Varsani",
"affiliation": {
"@type": "Organization",
"name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA."
}
},
{
"@type": "Person",
"name": "Giacomo Fais",
"url": "https://questionsmedicales.fr/author/Giacomo%20Fais",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Mattia Casula",
"url": "https://questionsmedicales.fr/author/Mattia%20Casula",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Pierluigi Caboni",
"url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Giacomo Cao",
"url": "https://questionsmedicales.fr/author/Giacomo%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Economic burden of chronic pain in Alberta, Canada.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35960750",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0272638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Farming and the risk of developing osteoarthritis in Alberta, Canada.",
"datePublished": "2024-05-24",
"url": "https://questionsmedicales.fr/article/38826129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.22605/RRH8383"
}
},
{
"@type": "ScholarlyArticle",
"name": "Immunization status of children at kindergarten entry in Alberta, Canada.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35864307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00663-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Barriers to Care for Poststroke Visual Deficits in Alberta, Canada.",
"datePublished": "2022-08-01",
"url": "https://questionsmedicales.fr/article/35912690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/cjn.2022.280"
}
},
{
"@type": "ScholarlyArticle",
"name": "The standardization of the Polish version of the Alberta Infant Motor Scale.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37173690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12887-023-04055-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture virale",
"item": "https://questionsmedicales.fr/mesh/D014776"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture virale",
"description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture virale",
"description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture virale",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture virale",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture virale",
"description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Alberta#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test de culture virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont utilisés pour la culture virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests complètent la culture virale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale."
}
},
{
"@type": "Question",
"name": "Combien de temps prend une culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection virale dans une culture ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec une infection virale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une culture virale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "La culture virale aide-t-elle à choisir un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables aux complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement."
}
}
]
}
]
}
2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA.
3Structural Biology Research Unit, Department of Integrative Biomedical Sciences, University of Cape Town, Observatory, Cape Town, South Africa.
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America; College of Life Science, Qingdao University, Qingdao, PR China.
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America. Electronic address: keg005@uark.edu.
Although chronic pain (CP) is common, little is known about its economic burden in Alberta, Canada....
To estimate incremental (as compared to the general population or people without CP) societal (healthcare and lost productivity) costs of CP in Alberta....
We applied the prevalence estimated from the Canadian Community Health Survey data to the population retrieved from the Statistics Canada to estimate the number of people with CP in Alberta in 2019. W...
The prevalence of any CP was 20.1% and of activity-preventing CP was 14.5% among people aged > = 12 years. Incremental cost per person with CP per year was CA$2,217 for healthcare services (among peop...
Interventions improving CP prevention and management to reduce this substantial economic burden are urgently needed....
Because farming is a physically demanding occupation, farmers may be susceptible to developing osteoarthritis (OA). The aim of this study was to determine the risk of developing OA in Canadian farm, n...
A retrospective cohort study of five Alberta health administrative databases examined the risk of developing OA among three groups: farm (n=143 431), non-farm rural (n=143 431) and urban (n=143 431) r...
A total of 26 957 OA cases were identified among 1 706 256 person-years (PYs) in the farm cohort. The crude incidence rate of OA over a period of 21 years ranged from 19.1 (95% confidence interval (CI...
When accounting for age and sex, farm and non-farm rural residents have a higher risk of developing OA as compared to the urban population. The higher mortality-adjusted lifetime risk of developing OA...
Little is known about immunization coverage among kindergarten-aged children in jurisdictions that do not require children's immunization records to be provided at school entry. Thus, we assessed immu...
This retrospective cohort study used population-based administrative health data for childhood vaccines in Alberta, Canada. We categorized and compared immunization status of children as follows: (a) ...
Immunization coverage for the complete vaccine series for children (N = 41,515) at kindergarten entry was suboptimal (44.5%, 95% CI 44.0-45.0) and substantially lower than for children at the end of g...
Immunization coverage at kindergarten entry was strikingly low. Risk factors for incomplete immunization status were identified that require particular attention when addressing immunization coverage....
Poststroke visual impairment (VI) negatively affects rehabilitation potential and quality of life for stroke survivors. In this cross-sectional observational study, stroke survivors and providers were...
The Alberta Infant Motor Scale (AIMS) is a standardized tool for assessing gross motor development from birth through independent walking (0-18 months). The AIMS was developed, validated and standardi...
The research involved 431 infants (219 girls, 212 boys, aged 0-<19 months), divided into nineteen age groups. The translated into Polish and validated version of the AIMS was used. The mean AIMS total...
The mean AIMS total scores in the Polish population were significantly lower in the seven age groups: 0-<1, 1-<2, 4-<5, 5-<6, 6-<7, 13-<14, and 15-<16 months of age (with small to large effect size). ...
Our study provides the norms for the Polish AIMS version. According to differences in the mean AIMS total scores and percentiles, the original Canadian reference values are not congruent for Polish in...
ClinicalTrials.gov ID NCT05264064. URL https://clinicaltrials.gov/ct2/show/NCT05264064 . Date of registration: 03/03/2022....
Very little is known about how the COVID-19 pandemic has affected the health of residents and the healthcare system in Alberta, Canada. The purpose of this study is to establish an observational study...
This is a population-level provincial observational study which will follow-up with Alberta residents who underwent testing for COVID-19 and completed surveys adapted from the ISARIC COVID-19 long-ter...
This study was reviewed and approved by the University of Alberta ethics committee (Study ID: Pro00112053 & Pro00113039) on 13 August 2021 and adheres to the Alberta Health Services research informati...
6 June 2022 EUROQOL ID: 161 015....
LDL-C, a cardiovascular disease risk assessment biomarker, is commonly calculated using the Friedewald equation. The NIH equation overcomes several limitations of the Friedewald equation. Consistent w...
1-year (01/01/2021-12/31/2021) of lipid results (n = 1,486,584 after data cleaning) were obtained from five analytical instrument groups used across Alberta. Analyses were performed on all data and af...
Friedewald- and NIH-calculated LDL-C exhibit the strongest correlation when triglycerides ≤ 4.52 mmol/L. The difference between Friedewald- and NIH-calculated LDL-C increases with decreasing LDL-C con...
Our findings demonstrate the benefits of implementing the NIH equation across Alberta....
Data on the incidence and characteristics of stillbirths attributed to congenital syphilis were collected....
We extracted data on stillbirths in the Edmonton Zone on January 1, 2015, through June 30, 2021, born to persons diagnosed with infectious syphilis (primary, secondary, early latent, or early neurosyp...
Of 314 infants documented to be exposed to infectious syphilis during gestation, 16 (5.1%) were stillborn. Three of the 16 females with stillbirths were diagnosed with syphilis during pregnancy but no...
Stillbirths due to congenital syphilis were all due to failure to treat syphilis in pregnancy. Innovative strategies to prevent syphilis in the community and to reach those experiencing barriers to ca...
Triage is the process of identifying patients with both the greatest clinical need and the greatest likelihood of benefit in the setting of limited clinical resources. The primary objective of this st...
Data from the Alberta Trauma Registry (ATR) was used to assess seven triage tools: START, JumpSTART, SALT, RAMP, MPTT, BCD and MITT. Clinical data captured in the ATR was used to determine which triag...
Of the 9448 records that were captured 8652 were included in our analysis. The most sensitive triage tool was MPTT, which demonstrated a sensitivity of 0.76 (0.75, 0.78). Four of the seven triage tool...
There was a wide range in the sensitivity of triage tools to identify patients requiring urgent lifesaving interventions. MPTT, BCD and MITT were the most sensitive triage tools assessed. All of the t...
To describe and quantify independent prescribing of oncology pharmacists working in adult, ambulatory cancer centers in Alberta, Canada....
A retrospective chart review of oncology pharmacists prescribing in the electronic health record, ARIA...
Over 6 months, 3474 prescriptions were ordered by 33 clinically deployed pharmacists. The median number of medications prescribed was 7 per month (interquartile range: 1.50-27.00; Range: 0.17-79.5). W...
Oncology pharmacists utilize their independent prescribing to initiate and continue supportive care medications for cancer patients. The prescribing volume varied greatly among pharmacists. Opportunit...